<DOC>
	<DOCNO>NCT02542462</DOCNO>
	<brief_summary>This prospective randomized clinical trial aim evaluate potential effect first dose rotavirus vaccine gastrointestinal motility anatomy blood stool cytokine response . It also assess association outcome pattern shed vaccine strain rotavirus stool . Infants randomize one four arm : monovalent rotavirus vaccine ( Rotarix® , RV1 ) alone , RV1 recommend vaccine , pentavalent rotavirus vaccine ( RotaTeq® , RV5 ) alone , RV5 recommend vaccine . Data derive pilot study use assess feasibility conduct large scale study .</brief_summary>
	<brief_title>Potential Mechanisms Intussusception After Rotavirus Vaccine-Pilot Study</brief_title>
	<detailed_description>Healthy infant 6-13 week age randomize ( 1:1:1:1 ) receive either , RV1 alone , RV1 Advisory Committee Immunization Practices ( ACIP ) routinely recommended immunization ( Diphtheria , Tetanus Pertussis ( DTaP ) , Haemophilus influenza type b ( Hib ) , pneumococcal conjugate ( PCV13 ) , Hepatitis B ( HBV ) inactivate polio ( IPV ) ) , RV5 alone RV5 ACIP routinely recommend immunization . Imaging study personnel parent blind rotavirus vaccine type ; parent inform rotavirus vaccine type completion study . Up 100 infant enrol . Recruitment enrollment occur prior first clinic visit . There four study visit include recruitment/enrollment visit three clinic visit . Infants randomize either RV1 , RV1 plus immunization , RV5 alone , RV5 plus immunization . Clinic Visit 1 ( day 0 ) include blood , saliva , stool breast milk collection . The MRI ultrasound perform prior vaccination . Children receive immunization randomize . Imaging personnel parent blind rotavirus vaccine type ; inform vaccine administer . A second MRI ultrasound perform Clinic Visit 2 ( day 5 ) blood stool sample collect . Parents unblinded completion Clinic Visit 3 ( day 14 ) . Arrangements make get remaining dos rotavirus vaccine . Daily stool sample collect home 15 day study period ( vaccination day 0 next 14 day ) . A memory aid complete collect reactogenicity data day 0 next 14 day . Remaining stools reactogenicity data parent collect Visit 3 . The investigator assess blood stool cytokine responses intestinal anatomy motility rotavirus vaccination compare pre-vaccination post-vaccination response study infant . Cytokines intestinal anatomy motility assess baseline ( Visit 1 , day vaccine receipt ) 5 day vaccination ( Visit 2 ) . For blood stool , follow cytokine test : IL-2 , IL-6 , IL-7 , IL-8 , IL-15 , INF-γ TNF-α . Additional biomarkers may study .</detailed_description>
	<mesh_term>Intussusception</mesh_term>
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1. healthy infant 6 13 week ( 12 week 6 day ) age day rotavirus vaccine administration 2. free obvious health problem establish medical history confirm infant 's primary physician prior Visit 1 3. parent/legal guardian willing infant feed bottle contrast 4. parent/legal guardian willing capable signing inform consent 5. parent/legal guardian infant expect available entire study 6. parent/legal guardian reach telephone 7. parent/legal guardian express willingness complete study procedure receive 2 month immunization , accord recommend schedule 1. gestational age &lt; 37 week 2. infant unable fast 4 hour prior MRI procedure 3. receipt vaccine except initial HBV ( must least 28 day HBV Visit 1 include ) 4. history severe allergic reaction HBV vaccine 5. contraindication routine vaccine 1 . Severe Combined Immune Deficiency 2. history intussusception 6. precaution either RV1 RV5 ( may interfere study outcome ) a. alter immunocompetence i. infant primary acquire immunodeficiency state , cellular immunodeficiency , hypogammaglobulinemic dysgammaglobulinemic state ii . infant blood dyscrasia , leukemia , lymphoma , malignant neoplasm affect bone marrow lymphatic system iii . infant immunosuppressive therapy ( include highdose systemic corticosteroid ) iv . infant HIVexposed infected b. acute gastroenteritis c. moderate severe acute illness without fever d. preexist chronic gastrointestinal disease ( e.g. , congenital malabsorption syndrome , Hirschsprung 's disease , shortgut syndrome ) e. infant spina bifida bladder exstrophy ( latex rubber contain RV1 oral applicator ) 7. sensitivity latex ( latex rubber contain RV1 oral applicator ) 8. febrile illness within previous 14 day ( axillary temperature 100.4◦ F high ) 9. history vomiting ( forceful expulsion partially digest milk/food ) and/or diarrhea ( 3 watery stool ) within 14 day Visit 1 10. receipt steroid , immunoglobulin , blood products/transfusion 11. receipt nonsteroidal antiinflammatory drug previous 72 hour ( may affect cytokine response ) 12. receipt antipyretic medication ( acetaminophen ibuprofen ) within 72 hour prior first dose rotavirus vaccine already plan administer prophylactic antipyretic medication day day follow vaccination ( exclusion apply caretaker indicate he/she might administer antipyretic vaccination reduce fever ) 13. enrol plan enroll another clinical trial investigational product participate study ( observational study allow ) 14. condition , opinion investigator , may post health risk subject interfere MRI vaccine evaluation 15. currently receive medication gastroesophageal reflux ( GERD ) gastrointestinal condition include colic 16. infant relative research study personnel 17. allergy barium 18. fail newborn hearing screening</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>90 Days</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>mechanism intussusception</keyword>
	<keyword>rotavirus vaccine</keyword>
</DOC>